Ligand validation:4WMZ

TPF: 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL

TPF is a Ligand Of Interest in 4WMZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WMZ_TPF_A_602	54%	6%	0.214	0.98	1.92	3.14	3	9	0	0	100%	1
5ESJ_TPF_A_602	74%	73%	0.141	0.973	0.48	0.58	-	-	1	0	100%	1
5ESF_TPF_A_602	67%	70%	0.168	0.978	0.53	0.61	-	-	0	0	100%	1
4ZE3_TPF_A_602	63%	72%	0.175	0.97	0.52	0.55	-	-	0	0	100%	1
5ESM_TPF_A_602	51%	73%	0.213	0.97	0.5	0.53	-	-	0	0	100%	1
5ESE_TPF_A_602	45%	75%	0.233	0.967	0.48	0.5	-	-	1	0	100%	1
2IJ7_TPF_B_2470	90%	1%	0.079	0.962	3.74	4.68	9	13	0	0	100%	1
6MA7_TPF_A_602	87%	9%	0.098	0.97	2.66	1.82	6	6	1	0	100%	1
6H1S_TPF_A_501	81%	7%	0.119	0.971	2.23	2.57	5	11	0	0	100%	1
2WX2_TPF_B_1460	76%	8%	0.118	0.953	2.13	2.43	2	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.